BBHC
COLL icon

Brown Brothers Harriman & Co’s Collegium Pharmaceutical COLL Stock Holding History

Brown Brothers Harriman & Co’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.04K Hold
243
– – ﹤0.01% 1395
2025
Q4 		$11.3K Hold
243
– – ﹤0.01% 1311
2025
Q3 		$8.5K Buy
+243
New +$8.45K ﹤0.01% 1311

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Brown Brothers Harriman & Co's COLL Position: Q1 2026 in Review

Brown Brothers Harriman & Co held its Collegium Pharmaceutical (COLL) position steady in Q1 2026 at 243 shares worth $8.04K. The position accounts for ﹤0.01% of the portfolio, ranked #1395.

Brown Brothers Harriman & Co first reported a position in COLL in Q3 2025 and has held it in 3 quarters since. The position peaked at $11.3K in Q4 2025. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Brown Brothers Harriman & Co held 243 shares of Collegium Pharmaceutical worth $8.04K as of Q1 2026.
  • Brown Brothers Harriman & Co left its Collegium Pharmaceutical share count unchanged in Q1 2026.
  • Collegium Pharmaceutical made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q1 2026, its #1395 holding.
  • Brown Brothers Harriman & Co first reported a position in Collegium Pharmaceutical in Q3 2025 and has held it in 3 quarters since.
  • Brown Brothers Harriman & Co's Collegium Pharmaceutical position peaked at $11.3K in Q4 2025.
  • 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q1 2026, filed 14 May 2026.